| TA197 |
Atrial fibrillation - dronedarone (TA197) |
|
-
-
Dronedarone for the treatment of non-permanent atrial fibrillation
NICE recommends dronedarone as a possible treatment for some people with non-permanent atrial fibrillation.
Who can have dronedarone?
You should be able to have dronedarone if:
- you have already tried another type of drug (usually a drug called a beta-blocker) but this has not worked, and
- you have at least one of the following which means you are at a higher risk of developing disease of the heart or blood vessels:
- you are taking at least two different types of drugs for high blood pressure
- you have diabetes
- you have had a type of stroke or a blood clot in the past
- the left chamber of your heart is larger than normal
- your heart is pumping less blood around your body than normal, or
- you are 70 or over, and
- you do not have a severe form of heart failure; that is, if you have been diagnosed as having heart failure, you are still able to carry out everyday tasks with either no symptoms, or symptoms that are mild (for example, you may experience mild chest pain or shortness of breath when walking or climbing the stairs).
-
Other information
How this guidance was produced
Background information
This page was last updated: 01 February 2011
-
Guidance formats
-
Implementation tools and resources
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guidance
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
Full Guidance
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
